| | | | | | | | |
Immunohistochemistry
| |
|---|
|
Author(s)
|
Age (y)
|
Size (cm)
|
PD
|
Rupture
|
Adhesion
|
Surgery
|
Mitoses (MF/10 HRP)
|
Ki-67 PI
|
Vimentin
|
SMA
|
α-inhibin
|
Calretinin
|
EMA
|
Prognosis
|
|---|
|
Kaku et al. [11]
|
32
|
6.6 × 6.0 × 4.4
|
OT
|
–
|
–
|
LSO
|
17
|
50
|
+
|
+
|
ND
|
ND
|
ND
|
12 month NED
|
|
Bucella et al. [12]
|
65
|
10.0 (First)
|
OT
|
–
|
–
|
TAH, BSO
|
4
|
9
|
+
|
ND
|
Focal+
|
ND
|
ND
|
Recurrence twice NED
|
|
12.0 (Second)
|
|
8.0 (Third)
|
|
Monteiro et al. [13]
|
13
|
19.0 × 15.0 × 12.0
|
OT
|
–
|
Omentum
|
RSO, OMT
|
5–7
|
ND
|
ND
|
ND
|
ND
|
ND
|
ND
|
36 month NED
|
|
Wu et al. [14]
|
76
|
9.0 × 6.0 × 5.0
|
PM
|
–
|
–
|
TAH, BSO
|
5–9
|
>10
|
+
|
ND
|
+
|
–
|
–
|
ND
|
|
Zong et al. [15]
|
39
|
10.0 × 7.0 × 4.0
|
OT
|
+
|
Left latum & uterus
|
TAH, LSO, OMT, AD, LD
|
3–5
|
10
|
+
|
+
|
ND
|
ND
|
–
|
66 month NED
|
|
Yamada et al. [16]
|
36
|
6.0
|
OT
|
ND
|
–
|
LS (RSO)
|
10
|
8.7
|
+
|
ND
|
Focal+
|
–
|
–
|
6 month NED
|
|
Present case
|
44
|
5.9 (First)
|
Myoma
|
–
|
–
|
LS (First), TAH, LSO, OMT (Second)
|
6.7
|
9.5
|
+
|
+
|
Focal+
|
–
|
–
|
26 month NED
|
|
11.0 (Second)
|
-
Abbreviations: α alpha, AD appendectomy, BSO bilateral salpingo-oophorectomy, EMA epithelial membrane antigen, HRP high power field, LD lymph node dissection, LS laparoscopic surgery, LSO left salpingo-oophorectomy, MF mitotic figure, ND not described, NED no evidence of disease, OMT omentectomy, OT ovarian tumor, PD preoperative diagnosis, PI proliferative index, PM pelvic mass, RSO right salpingo-oophorectomy, SMA smooth muscle actin, TAH total abdominal hysterectomy, y year, + positive, − negative
